Project/Area Number |
10557062
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 展開研究 |
Research Field |
Neurology
|
Research Institution | KYUSHU UNIVERSITY |
Principal Investigator |
KIRA Jun-ichi Kyushu University, Medical Science, Professor, 大学院・医学系研究科, 教授 (40183305)
|
Co-Investigator(Kenkyū-buntansha) |
KOYANAGI Yoshio Tohoku University, Medical Science, Professor, 大学院・医学研究科, 教授 (80215417)
IWAKI Toru Kyushu University, Medical Science, Professor, 大学院・医学系研究科, 教授 (40221098)
原 英夫 九州大学, 医学部, 講師 (00260381)
|
Project Period (FY) |
1998 – 1999
|
Project Status |
Completed (Fiscal Year 1999)
|
Budget Amount *help |
¥5,300,000 (Direct Cost: ¥5,300,000)
Fiscal Year 1999: ¥1,800,000 (Direct Cost: ¥1,800,000)
Fiscal Year 1998: ¥3,500,000 (Direct Cost: ¥3,500,000)
|
Keywords | HTLV-I / HAM / Myelopathy / Arthritis / animal models / MT-2 / infectious cDNA clone / キメラ / HTLV-1 / 感染症cDNAクローン / ラット / クローン / サイトカイン / Th1 / Th2バランス / 中枢神経 / 末梢神経 |
Research Abstract |
Human T-lymphotropic virus type 1 (HTLV-I) is closely linked to HTLV-associated myelopathy (HAM), arthritis, uveitis and bronchial alveolitis. Immunological changes caused by HTLV-I infection may affect the condition, but the pathomechanism remains unknown. To elucidate the pathomechanism of these diseases, it is important to make animal models. Although induction of HAM-like paraparesis through experimental infection of WKA rats with HTLV-I has been reported, neither inflammatory changes nor alteration of the immune response has been observed in these animals. In addition, HTLV-I transgenic mice or rat has been reported to induce rheumatoid arthritis (RA)-like but not HAM-like myelopathy. We established many HTLV-infected T cell lines from HAM patients. One of them (Fuk line) inoculated to WKA rat caused RA-like arthritis. On the other hand, when MT-2, which is a HTLV-infected T cell line derived from ATL patient, was inoculated to WAK rats, they developed myeloneuropathy. These findings suggest that clinical expression in part depends on the HTLV-infected cell lines inoculated. Recently, it becomes technically possible to make infectious cDNA clones of HTLV-I. So, we tried to make infections cDNA clones from MT-2 cells and Fuk cells, respectively, to clarify which portion of HTLV-I genome play a pivotal role for the induction of myelopathy or arthritis. We sequenced the HTLV-I proviral DNA of MT-2 and Fuk line and found several mutations producing amino acid substitution in the pX region of HTLV-I derived from Fuk cells. It is now underway to make infections cDNA clone of HTLV-I of each cell lines.
|